Clinical Trial Update: STOP HCC-GAAD-APAC-Thailand [NA]

View source ↗

Summary

The STOP HCC-GAAD-APAC-Thailand trial sponsored by Mahidol University is currently enrolling by invitation for hepatocellular carcinoma in patients with cirrhos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis B
• Hepatocellular Carcinoma

Snippet

Sponsor: Mahidol University | Conditions: Hepatecellular Carcinoma, Cirrhosis | NA | Status: ENROLLING_BY_INVITATION